NanJing Pharmaceutical Company Limited reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 53,473.37 million compared to CNY 50,074.09 million a year ago. Revenue was CNY 53,589.66 million compared to CNY 50,221.56 million a year ago.

Net income was CNY 577.83 million compared to CNY 595.67 million a year ago. Basic earnings per share from continuing operations was CNY 0.445 compared to CNY 0.475 a year ago. Diluted earnings per share from continuing operations was CNY 0.445 compared to CNY 0.475 a year ago.